MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Organization & Developments: White House
*Organization: White House
*Government: U.S. Federal
U.S. Government Departments and Agencies_Executive Branch_A-Z Index
Government: Federal (U.S.)_Cabinet Departments
HHS (Department of Health & Human Services)
Organization & Developments: HHS
BARDA (Biomedical Advanced Research and Development Authority), HHS
Organization & Developments: BARDA
Parents
BARDA (Biomedical Advanced Research and Development Authority), HHS
Organization & Developments: ASPR
Children
*BARDA, a center within ASPR, improves preparedness and response through public-private partnerships that advanced research and development, manufacturing, and procurement of medical countermeasures that protect against health security threats, such as chemical, biological, radiological, and nuclear incidents, pandemic influenza, COVID-19, and other emerging infectious diseases.
*NIH_ACTIV, Accelerating COVID-19 Therapeutic Interventions and Vaccines
2011: BARDA funds development of five drugs to protect against radiation (2011)
2011: Novel anthrax vaccine and antitoxin being developed with federal support (2011)
2017: BARDA_Velico Medical raises another $19m for Frontline ODP spray-dried plasma – MassDevice
2017: Johnson & Johnson, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D for up to $273 million over 5 years
2018: BARDA 2018 Industry Day: Speakers
2018: HHS launches new initiative to address health concerns as national security threats
2018: HHS, BARDA _ INNOVATION TO ADDRESS PUBLIC HEALTH IMPERATIVES_ Presentations_Industry Day
2020: BARDA backs development of Hologic's high-throughput coronavirus test
2020: BARDA hands AstraZeneca $1B-plus to race through PhIII and ramp up fall deliveries of Oxford’s pandemic vaccine – Endpoints News
2020: BARDA_Backed by BARDA, Merck jumps into Covid-19: buying out a vaccine, partnering on another and adding antiviral to the mix – Endpoints News
2020: BARDA_Breakthrough Ebola Treatment Receives Contract from U.S. Government_BARDA
2020: BARDA_Phlow_BARDA offers a tiny startup up to $812M to create a US-based drug manufacturer
2022: NIAID_NIH announces $577 million antiviral drug development awards to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern
2022: NIOSH_“Mask Innovation Challenge: Building Tomorrow’s Mask”: Top 40 Semi-Finalists
2022: NIOSH/BARDA_HHS announces winners of mask innovation challenge
2023: BARDA Industry Day 2023_November 13 & 14, Hybrid: Grand Hyatt Washington & Virtual
2023: HHS awards $1.4B in grants to develop future COVID-19 tools
2023: Sanofi, BARDA break ground on another flu vaccine plant at campus in Swiftwater, Pennsylvania
2024: BARDA Launches the Next Generation of the BARDA Accelerator Network to Source and Support Startups across the U.S. and Globally
2024: Bird flu puts BARDA back in the spotlight
2025: 2nd Annual General Membership Meeting Rapid Response Partnership Vehicle (RRPV) consortium, 26-27 August, Arlington, Virginia
2025: BARDA cancels annual Industry Day
2025: Fact Sheet: HHS’ Transformation to Make America Healthy Again
2025: HHS Announces “Dramatic Restructuring”
2025: HHS Announces Transformation to Make America Healthy Again
2025: HHS to reduce workforce by 20K jobs in major agency-wide restructure
2025: Kennedy says BARDA to cancel work on future mRNA vaccines, claiming they ‘don’t perform well’
2025: RFK Jr. announces big cuts to Department of Health and Human Services
2025: RFK Jr.’s massive cuts stun staff, leave senior employees scrambling
As well as the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infecti
BARDA awards up to $143 million for advanced development of a new drug to treat anthrax
BARDA Biopharmaceutical Manufacturing Preparedness (BioMaP) program
BARDA DRIVe EZ-BAA
BARDA DRIVe_Beyond The Needle Program
BARDA is seeking additional proposals for vaccines, antitoxins, and therapeutics that potentially protect against anthrax infection.
BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical
BARDA Strategic Plan 2022-2026 One Pager - Medical Countermeasures
BARDA Ventures Program
BARDA_CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)
BARDA_Medical Countermeasures: Influenza & Emerging Infectious Diseases (IED) Pandemic Vaccines & Adjuvants Program
Clinical Studies Network, BARDA
HHS Awards Contracts Totaling More Than $19 Million to Advance the Development of New Therapeutics for the Treatment of Exposure
In addition, BARDA manages the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).
Project Bioshield
Provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and dia
Rapid Response Partnership Vehicle (RRPV), BARDA
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparednes
Jumps
*Contractors & Awardees: BARDA
*Funding: HHS_BARDA
*Key People: BARDA